Literature DB >> 19637983

Chitosan and its salts for mucosal and transmucosal delivery.

Maria Cristina Bonferoni1, Giuseppina Sandri, Silvia Rossi, Franca Ferrari, Carla Caramella.   

Abstract

This review considers the application of chitosan and its salts in the delivery of drugs intended to act locally towards diseases of the mucosa itself (mucosal delivery), and to undergo systemic absorption by means of transmucosal routes (transmucosal delivery). Those chitosan properties that are particularly useful in mucosal and transmucosal delivery have been reviewed, such as mucoadhesion, penetration enhancement and peptidase inhibition behaviour. Chitosan bioactive properties have also been considered, such as anti-infective, haemostatic, wound healing and immune-stimulating activity. Chitosan is available with a wide range of molecular mass and deacetylation degree: the influence of these properties on polymer performance and solubility has been taken into account. As solubility in particular can strongly limit the results obtained at pH values close to neutrality, particular attention has been paid to chitosan salts and derivatives with modified solubility. Thanks to the presence of positively charged amino groups of the polymer, a subject of increasing interest is the exploitation of its interaction with acidic molecules having potential synergistic behaviour towards bioactive properties, or even with acidic drugs. The aim of the review is to describe not only some properties of chitosan, but also the way they can be modified by the acidic moiety.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19637983     DOI: 10.1517/17425240903114142

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  10 in total

Review 1.  Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.

Authors:  Anumita Chaudhury; Surajit Das
Journal:  AAPS PharmSciTech       Date:  2010-12-11       Impact factor: 3.246

Review 2.  Enhancing the buccal mucosal delivery of peptide and protein therapeutics.

Authors:  Thiago Caon; Liang Jin; Cláudia M O Simões; Raymond S Norton; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-08-29       Impact factor: 4.200

3.  Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.

Authors:  Sai Prachetan Balguri; Goutham R Adelli; Soumyajit Majumdar
Journal:  Eur J Pharm Biopharm       Date:  2016-10-25       Impact factor: 5.571

Review 4.  Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review.

Authors:  Paola Mura; Francesca Maestrelli; Marzia Cirri; Natascia Mennini
Journal:  Mar Drugs       Date:  2022-05-20       Impact factor: 6.085

5.  Improvement of dissolution behavior of poorly water soluble drugs by biodegradable polymeric submicron carriers containing sparingly methylated β-cyclodextrin.

Authors:  Dilesh J Singhavi; Shagufta Khan; Pramod G Yeole
Journal:  J Mater Sci Mater Med       Date:  2013-02-08       Impact factor: 3.896

6.  Structural and Functional Analysis of the Complex between Citrate and the Zinc Peptidase Carboxypeptidase A.

Authors:  Daniel Fernández; Ester Boix; Irantzu Pallarès; Francesc X Avilés; Josep Vendrell
Journal:  Enzyme Res       Date:  2011-07-25

Review 7.  Marine polysaccharides in microencapsulation and application to aquaculture: "from sea to sea".

Authors:  Massimiliano Borgogna; Barbara Bellich; Attilio Cesàro
Journal:  Mar Drugs       Date:  2011-12-08       Impact factor: 6.085

8.  Association of Alpha Tocopherol and Ag Sulfadiazine Chitosan Oleate Nanocarriers in Bioactive Dressings Supporting Platelet Lysate Application to Skin Wounds.

Authors:  Maria Cristina Bonferoni; Giuseppina Sandri; Silvia Rossi; Eleonora Dellera; Alessandro Invernizzi; Cinzia Boselli; Antonia Icaro Cornaglia; Claudia Del Fante; Cesare Perotti; Barbara Vigani; Federica Riva; Carla Caramella; Franca Ferrari
Journal:  Mar Drugs       Date:  2018-02-09       Impact factor: 5.118

9.  Chitosan Coated Microparticles Enhance Simvastatin Colon Targeting and Pro-Apoptotic Activity.

Authors:  Nabil A Alhakamy; Usama A Fahmy; Osama A A Ahmed; Giuseppe Caruso; Filippo Caraci; Hani Z Asfour; Muhammed A Bakhrebah; Mohammad N Alomary; Wesam H Abdulaal; Solomon Z Okbazghi; Ashraf B Abdel-Naim; Basma G Eid; Hibah M Aldawsari; Mallesh Kurakula; Amir I Mohamed
Journal:  Mar Drugs       Date:  2020-04-24       Impact factor: 5.118

10.  Diaminated Starch: A Competitor of Chitosan with Highly Mucoadhesive Properties due to Increased Local Cationic Charge Density.

Authors:  Akram Nouri; Max Jelkmann; Sepideh Khoee; Andreas Bernkop-Schnürch
Journal:  Biomacromolecules       Date:  2020-01-30       Impact factor: 6.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.